BetaCell PodcastPodcast RSS

About the Podcast

Listen to experts discuss new concepts, emerging research and current therapeutic options related to beta cells in diabetes.

FAQ: What impact does lifestyle modification have on beta cell physiology and the progression of T2DM?

Frequently asked questions for the primary care community, excerpted from a conversation between a leading primary care physician and a world-renowned beta cell researcher. (3:59)

You are missing some Flash content that should appear here. You may need to download the most recent version of the Flash player, available for free here.

FAQ: How durable are the effects of drugs used to treat type 2 diabetes?

Frequently asked questions for the primary care community, excerpted from a conversation between a leading primary care physician and a world-renowned beta cell researcher. (3:56)

You are missing some Flash content that should appear here. You may need to download the most recent version of the Flash player, available for free here.

FAQ: Are there any differences between sulfonylureas and incretins in terms of weight effects?

Frequently asked questions for the primary care community, excerpted from a conversation between a leading primary care physician and a world-renowned beta cell researcher. (2:27)

You are missing some Flash content that should appear here. You may need to download the most recent version of the Flash player, available for free here.

FAQ: Why would I consider an incretin over a sulfonylurea, which has been known for over 50 years to promote insulin secretion by the beta cells?

Frequently asked questions for the primary care community, excerpted from a conversation between a leading primary care physician and a world-renowned beta cell researcher. (1:15)

You are missing some Flash content that should appear here. You may need to download the most recent version of the Flash player, available for free here.

FAQ: What impact do newer classes of drugs, such as the incretins, have on insulin secretion by the beta cells?

Frequently asked questions for the primary care community, excerpted from a conversation between a leading primary care physician and a world-renowned beta cell researcher. (3:45)

You are missing some Flash content that should appear here. You may need to download the most recent version of the Flash player, available for free here.

FAQ: Do any of the traditional drugs used to treat T2DM directly affect the beta cells?

Frequently asked questions for the primary care community, excerpted from a conversation between a leading primary care physician and a world-renowned beta cell researcher. (4:59)

You are missing some Flash content that should appear here. You may need to download the most recent version of the Flash player, available for free here.

FAQ: Why should the primary care community care what’s going on at the beta cell level if there’s no direct way to measure it right now?

Frequently asked questions for the primary care community, excerpted from a conversation between a leading primary care physician and a world-renowned beta cell researcher. (2:56)

You are missing some Flash content that should appear here. You may need to download the most recent version of the Flash player, available for free here.

FAQ: Are there tests that primary care physicians can use to gauge beta cell sensitivity or other measures of disease progression?

Frequently asked questions for the primary care community, excerpted from a conversation between a leading primary care physician and a world-renowned beta cell researcher. (1:07)

You are missing some Flash content that should appear here. You may need to download the most recent version of the Flash player, available for free here.

FAQ: What is happening to pancreatic beta cells in people with pre-diabetes?

Frequently asked questions for the primary care community, excerpted from a conversation between a leading primary care physician and a world-renowned beta cell researcher. (2:30)

You are missing some Flash content that should appear here. You may need to download the most recent version of the Flash player, available for free here.

FAQ: How has thinking changed about the relative roles of insulin resistance and secretion in the pathophysiology of T2DM?

Frequently asked questions for the primary care community, excerpted from a conversation between a leading primary care physician and a world-renowned beta cell researcher. (1:28)

You are missing some Flash content that should appear here. You may need to download the most recent version of the Flash player, available for free here.

|